Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability

Hypertension Research

Volumn 35, Issue 9, 2012, Pages 928-934

  Young Park, Ji ^a   Wook Yun, Jung ^a   Whan Choi, Young ^b   Ung Bae, Jin ^a   Won Seo, Kyo ^a   Jin Lee, Seung ^a   Youn Park, So ^a   Whan Hong, Ki ^a   Kim, Chi Dae ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

angiotensin II; gomisin A; nitric oxide; ROS

Indexed keywords

ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GOMISIN A; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MECHANISM; ENDOTHELIUM CELL; HYPERTENSION; MALE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SCHISANDRA CHINENSIS; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD VESSELS; CELLS, CULTURED; CYCLOOCTANES; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; LIGNANS; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SCHISANDRA; VASOCONSTRICTOR AGENTS;

EID: 84865980245     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.50     Document Type: Article

References (35)

1. Nguelefack TB, Dongmo AB, Dimo T, Kamanyi A. Phytopharmacology of some medicinal plants used in Cameroonian traditional medicine to handle cardiovascular diseases. In Anna Capasso (ed) Recent Developments in Medicinal Plant Research, 2007, pp 147-167. ISBN 978-81-308-0160-5.
2. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III27-III32. (Pubitemid 38786440)
3. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 2001; 299: 818-824. (Pubitemid 33104947)
4. Venema RC. Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin. Int Immunopharmacol 2002; 2: 1755-1762. (Pubitemid 35373918)
5. Schulz E, Jansen T, Wenzel P, Daiber A, Münzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 2008; 10: 1115-1126. (Pubitemid 351451710)
6. Watanabe T, Barker TA, Berk BC. Angiotensin II and the endothelium: diverse signals and effects. Hypertension 2005; 45: 163-169.
7. Nakashima H, Suzuki H, Ohtsu H, Chao JY, Utsunomiya H, Frank GD, Equchi S. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol 2006; 4: 67-78. (Pubitemid 46785183)
8. Virdis A, Duranti E, Taddei S. Oxidative stress and vascular damage in hypertension: role of angiotensin II. Int J Hypertens 2011; 2011: 916310.
9. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148. (Pubitemid 24176909)
10. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 2000; 101: 1722-1728. (Pubitemid 30196634)
11. Garrido AM, Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 2009; 302: 148-158.
12. Murdoch CE, Alom-Ruiz SP, Wang M, Zhang M, Walke S, Yu B, Breser A, Shah AM. Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Res Cardiol 2011; 106: 527-538.
13. Chen DF, Zhang SX, Xie L, Xie JX, Chen K, Kashiwada Y, Zhou BN, Wang P, Cosentino LM, Lee KH. Anti-AIDS agents-XXVI. Structure-activity correlations of gomisin-G-related anti-HIV lignans from Kadsura interior and of related synthetic analogues. Bioorg Med Chem 1997; 5: 1715-1723.
14. Chiu PY, Mak DH, Poon MK, Ko KM. In vivo antioxidant action of a lignan-enriched extract of schisandra fruit and an anthraquinone-containing extract of polygonum root in comparison with schisandrin B and emodin. Planta Med 2002; 68: 951-956. (Pubitemid 35448986)
15. Choi YW, Takamatsu S, Khan SI, Srinivas PV, Ferreira D, Zhao J, Khan IA. Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structureantioxidant activity relationships of dibenzocyclooctadiene lignans. J Nat Prod 2006; 69: 356-359.
16. Park JY, Lee SJ, Yun MR, Seo KW, Bae SS, Park JW, Lee YJ, Shin W., Choi YW, Kim CD. Gomisin A from Schisandra chinensis induces endothelium-dependent and direct relaxation in rat thoracic aorta. Planta Med 2007; 73: 1537-1542.
17. Park JY, Shin HK, Choi YW, Lee YJ, Bae SS, Han J, Kim CD. Gomisin A induces Ca2 +-dependent activation of eNOS in human coronary artery endothelial cells. J Ethnopharmacol 2009; 125: 291-296.
18. Kukongviriyapan V, Somparn N, Senggunprai L, Prawan A, Kukongviriyapan U, Jetsrisuparb A. Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-bata thalassemia. Pediatr Cardiol 2008; 29: 130-135.
19. Amer J, Goldfarb A, Fibach E. Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol 2003; 70: 84-90. (Pubitemid 36269554)
20. Lin LY, Lin CY, Su TC, Liau CS. Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett 2004; 574: 106-110.
21. Marrero MB, Venema VJ, Ju H, He H, Liang H, Caldwell RB, Venema RC. Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J 1999; 343: 335-340. (Pubitemid 29511765)
22. Sessa WC. eNOS at a glance. J Cell Sci 2004; 117: 2427-2429.
23. Nakmareong S, Kukongviriyapan U, Pakdeechote P, Donpunha W, Kukongviriyapan V, Kongyingyoes B, Sompamit K, Phisalaphong C. Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension. Naunyn Schmiedebergs Arch Pharmacol 2011; 383: 519-529.
24. Imanishi T, Kobayashi K, Kuroi A, Mochizuki S, Goto M, Yoshida K, Akasaka T. Effects of angiotensin II on NO bioavailability evaluated using a catheter-type NO sensor. Hypertension 2006; 48: 1058-1065. (Pubitemid 44772708)
25. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T. Effects of angiotensin II on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002; 90: e58-e65.
26. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases the role of oxidant stress. Circ Res 2000; 87: 840-844.
27. Loot AE, Schreiber JG, Fisslthaler B. Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase. J Exp Med 2009; 206: 2889-2896.
28. Ikeda Y, Aihar K, Yoshida S, Sato T, Yagi S, Iwase T, Sumitomo Y, Ise T, Ishikawa K, Azuma H, Akaike M, Kato S, Matsumoto T. Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling. Endocrinology 2009; 150: 2857-2864.
29. Sachse A, Wolf G. Angiotensin II-induced reactive oxygen species and the kidney. J Am Soc Nephrol 2007; 18: 2439-2446. (Pubitemid 47378859)
30. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP. gp91 phoxcontaining NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 2004; 109: 1795-1801. (Pubitemid 38500684)
31. Kuo YH, Kuo LM, Chen CF. Four new C19 homolignans, schiarisanrins A, B, and D and cytotoxic schiarisanrin C, from Schizandra arisanensis. J Org Chem 1997; 62: 3242-3245.
32. Chen YG, Qin GW, Xie YY, Cheng KF, Lin ZW, Sun HD, Kang YH, Han BH. Lignans from Kadsura angustifolia. J Asian Nat Prod Res 1998; 1: 125-131.
33. Zhang H, Schmeisser A, Garlichs CD, Plötze K, Damme U, Mügge A, Daniel WG. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res 1999; 44: 215-222. (Pubitemid 29431699)
34. Lavigne MC, Malech HL, Holland SM, Leto TL. Genetic demonstration of p47phoxdependent superoxide anion production in murine vascular smooth muscle cells. Circulation 2001; 104: 79-84. (Pubitemid 32623293)
35. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffirn EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 2004; 22: 535-542. (Pubitemid 38368487)